Trimedyne Free Cash Flow 2010-2016 | TMED.

Trimedyne free cash flow from 2010 to 2016. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Trimedyne Annual Free Cash Flow
2015 -0.81
2014 -0.13
2013 1.25
2012 -0.30
2011 -0.88
2010 0.60
2009 -0.19
Trimedyne Quarterly Free Cash Flow
2016-06-30 -0.04
2016-03-31 0.19
2015-12-31 0.06
2015-09-30 -0.81
2015-06-30 -0.67
2015-03-31 -0.66
2014-12-31 -0.51
2014-09-30 -0.13
2014-06-30 -0.14
2014-03-31 -0.12
2013-12-31 0.06
2013-09-30 1.25
2013-06-30 0.62
2013-03-31 0.18
2012-12-31 0.02
2012-09-30 -0.30
2012-06-30 -0.13
2012-03-31 -0.39
2011-12-31 -0.35
2011-09-30 -0.88
2011-06-30 -0.91
2011-03-31 -0.09
2010-12-31 -0.12
2010-09-30 0.60
2010-06-30 -1.03
2010-03-31 -0.67
2009-12-31 -0.42
2009-09-30 -0.19
2009-06-30 0.19
2009-03-31 -0.08
Sector Industry Market Cap Revenue
Computer and Technology LASERS-SYS/COMP $0.000B $0.000B
TRIMEDYNE, INC. is engaged primarily in the research and development, manufacture and sale of lasers and disposable laser devices in the medical field. It is also engaged in the development, manufacture and sale of plastic fiber-optic illumination devices through its subsidiary, Poly-Optical Products, Inc.
Stock Name Country Market Cap PE Ratio
GlycoMimetics (CBIO) United States $0.009B 0.00